Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study on Doxil and SDZ PSC 833 in the Treatment of AIDS-Associated Kaposi's Sarcoma and Other Advanced Malignancies

NCT00003207 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT00003207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00003207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study on Doxil and SDZ PSC 833 in the Treatment of AIDS-Associated Kaposi's Sarcoma and Other Advanced Malignancies
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Completed
Start date
March 31, 1998
Completion date
July 31, 2002
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma, unspecified adult solid tumor, protocol specific